Top Markets
Coin of the day
Lushang Freda Pharmaceutical Co.,Ltd. Lushang Freda Pharmaceutical Co.,Ltd.

Lushang Freda Pharmaceutical Co.,Ltd.

600223
Rang in Aktien #10388
Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development,... Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant extracts, chemical synthesis, tablets, capsules, drinks, injections, granules, and other products. The company offers its products through online and offline channels. It exports its products to North America, the European Union, Japan, South Korea, and Southeast Asia. The company was formerly known as Lushang Health Industry Development Co.,Ltd. and changed its name to Lushang Freda Pharmaceutical Co.,Ltd. in April 2023. The company was founded in 1993 and is based in Jinan, China. Lushang Freda Pharmaceutical Co.,Ltd. is a subsidiary of Shandong Commercial Group Co.,Ltd.
Aktienkurs
$0.83325484
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$847.06M
Veränderung (1 Tag)
0.70%
Veränderung (1 Jahr)
-26.10%
Land
CN
Handel Lushang Freda Pharmaceutical Co.,Ltd. (600223)

Kategorie

Aktien-Split-Historie für Lushang Freda Pharmaceutical Co.,Ltd. (600223)
Die Aktie Lushang Freda Pharmaceutical Co.,Ltd. (Symbol: 600223) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 30, 2026 statt.
Eine 600223-Aktie, die vor dem Aug 30, 2026 gekauft wurde, entspricht heute 0 600223-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber